Innovation Ventures ☰
  • Partnering Opportunities
  • Innovator
  • Partner
  • Investor
  • About

Refine by

Category
Technology Type
Area of Interest
Stage of Development
Patent Status

Partnering Opportunities


  • Neurology

    Multi-Frequency Encoded Source Imaging

    A new imaging technology to localize and visualize electrical and/or magnetic signals in two or more frequency ranges.

  • Gene and Cell therapy

    Pulmonary macrophage transplantation (PMT) therapy via a lentiviral vector

    Treatment for hereditary Pulmonary Alveolar Proteinosis (hPAP)

  • Neurology

    Histone Deacetylase 3 Inhibitors for Treating Demyelinating Diseases

    HDAC3 inhibitors enhance myelin repair in white matter injury and demyelinating diseases

  • Pulmonology

    Serum Biomarkers and Algorithm of Lung Decline in Cystic Fibrosis

    Novel serum protein biomarkers and functional data analysis-based algorithm used to develop a predictive test for lung function decline.

  • Pulmonology

    Method of Treating Cystic Fibrosis with Src Kinase Inhibitors

    Scientists have shown that src kinase inhibitors are effective at treating CF patients with a frame deletion of F508 in the CFTR gene.

  • Allergy

    Suppression of Food Allergy with Metformin

    Metformin prevents the development of food allergy and suppresses established food allergy in mouse models.

  • Infectious Disease

    Rotavirus Subunit Vaccine Based on Norovirus S Particle Platform

    A non-replicating subunit Rotavirus vaccine was developed by using a novel S particle platform and displaying recombinant antigens.

  • Education & Learning

    Tracking Daily Preventive Activities of Infection-Prone Patients

    An electronic token economy module that tracks and encourages infection-prone patients to adhere to daily preventive activities.

  • Oncology

    Inhibition of UBE2N as a Therapeutic Approach in MDS and AML

    Pharmacologic and genetic inhibition of UBE2N suppresses the function and viability of MDS/AML cells lines and patient samples. A commercially available compound has been identified.

  • Dermatology

    Rapid reliable method for collection of keratinocyte RNA and DNA samples from children.

    Rapid reliable method for collection of keratinocyte RNA, DNA, microbiome, proteins, lipids, and metabolites.

Next Page
  • Partnering Opportunities
  • Innovator
  • Partner
  • Investor
  • About

Innovation Ventures | Partnering to Change the Outcome

3333 Burnet Avenue, Cincinnati, Ohio 45229-3026 | 1-513-636-4285

© 1999-2021 Cincinnati Children's Hospital Medical Center